Trial of a Phosphodiesterase 4 Inhibitor for Idiopathic Pulmonary FibrosisNEW ENGLAND JOURNAL OF MEDICINEIF78.52022-08-251PRE
Nintedanib in Progressive Fibrosing Interstitial Lung DiseasesNEW ENGLAND JOURNAL OF MEDICINEIF78.52020-02-206PREAI
Nintedanib and Pirfenidone New Antifibrotic Treatments Indicated for Idiopathic Pulmonary Fibrosis Offer Hopes and Raises QuestionsAMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINEIF19.42015-02-01153PREAI
Pulmonary Fibrosis Associated with Aluminum Trihydrate (Corian) DustNEW ENGLAND JOURNAL OF MEDICINEIF78.52014-05-2923PREAI
Ascertainment of Individual Risk of Mortality for Patients with Idiopathic Pulmonary FibrosisAMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINEIF19.42011-08-15333OAAI
Rheumatoid Arthritis-Interstitial Lung Disease-associated MortalityAMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINEIF19.42011-02-01402OAAI
Treatment of Idiopathic Pulmonary Fibrosis with Etanercept An Exploratory, Placebo-controlled TrialAMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINEIF19.42008-11-01318PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向